Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock, Common	Additional Paid-In Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2021	$ 454,724	$ 645		$ 946,152	$ (161)	$ (491,912)
Beginning Balance (in shares) at Dec. 31, 2021		64,505,889
Issuance of common stock, net of issuance costs	108,138	$ 78		108,060
Issuance of common stock, net of issuance costs (in shares)		7,820,000
Issuance of common stock pursuant to exercise of stock options	631	$ 1		630
Issuance of common stock pursuant to exercise of stock options (in shares)		66,887
Issuance of common stock pursuant to vesting of restricted stock units (in shares)		10,168
Issuance of common stock related to acquisition	70,724	$ 34		70,690
Issuance of common stock related to acquisition (in shares)		3,420,774
Issuance of common stock related to earnout restricted stock units settlement (in shares)		5,101
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs	46,566	$ 33		46,533
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs (in shares)		3,291,922
Treasury stock purchases	(47)		$ (47)
Unrealized comprehensive gain (loss) on investments	(196)				(196)
Treasury stock purchases (in shares)		2,571
Stock-based compensation	31,009			31,009
Net loss	(221,863)					(221,863)
Ending Balance at Dec. 31, 2022	489,686	$ 791	(47)	1,203,074	(357)	(713,775)
Ending Balance (in shares) at Dec. 31, 2022		79,123,312
Issuance of common stock, net of issuance costs	188,885	$ 95		188,790
Issuance of common stock, net of issuance costs (in shares)		9,453,418
Issuance of common stock pursuant to exercise of stock options	2,231	$ 2		2,229
Issuance of common stock pursuant to exercise of stock options (in shares)		223,145
Issuance of common stock pursuant to vesting of restricted stock units		$ 4		(4)
Issuance of common stock pursuant to vesting of restricted stock units (in shares)		407,999
Issuance of common stock pursuant to exercise of warrants	7	$ 1		6
Issuance of common stock pursuant to exercise of warrant (in shares)		126,093
Issuance of common stock related to acquisition	0
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs	17,222	$ 10		17,212
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs (in shares)		948,300
Unrealized comprehensive gain (loss) on investments	676				676
Sale of treasury stock	56		$ 47	9
Stock-based compensation	39,406			39,406
Net loss	(245,595)					(245,595)
Ending Balance at Dec. 31, 2023	492,574	$ 903		1,450,722	319	(959,370)
Ending Balance (in shares) at Dec. 31, 2023		90,282,267
Issuance of common stock, net of issuance costs	182,528	$ 152		182,376
Issuance of common stock, net of issuance costs (in shares)		15,180,000
Issuance of common stock pursuant to exercise of stock options	3,211	$ 3		3,208
Issuance of common stock pursuant to exercise of stock options (in shares)		269,080
Issuance of common stock pursuant to vesting of restricted stock units		$ 7		(7)
Issuance of common stock pursuant to vesting of restricted stock units (in shares)		722,471
Issuance of common stock related to acquisition	0
Unrealized comprehensive gain (loss) on investments	(253)				(253)
Stock-based compensation	43,920			43,920
Net loss	(258,746)					(258,746)
Ending Balance at Dec. 31, 2024	$ 463,234	$ 1,065		$ 1,680,219	$ 66	$ (1,218,116)
Ending Balance (in shares) at Dec. 31, 2024		106,453,818